Our Vitamin B12 shot may be just what you need to get back to feeling your best
Key Takeaways Oral GLP-1 receptor agonists are now the primary areas of innovation with the promise of giving patients a more practical alternative to injectable obesity therapies and, hopefully, higher rates of long-term adherence growing from $1.95 billion revenue in 2025 to account for more than 48% of the market by 2035
Research shows GLP1R rs6923761 variants, MC4R rs17782313 polymorphisms, and FTO gene status correlate with variable appetite-suppression responses to GLP-1 agonists
The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity or 75 minutes of vigorous activity weekly, plus strength exercises on at least 2 days [14] Achieving and maintaining a healthy weight , as obesity is associated with altered metabolic hormone responses Prioritising sleep quality , as sleep deprivation affects multiple metabolic hormones Managing stress , which can impact appetite regulation and glucose control These approaches align with NICE guidance for preventing and managing type 2 diabetes (NG28) and obesity (CG189) and should be implemented as part of a holistic lifestyle approach
Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation